Jeffrey S. Heier, M.D.

Jeffrey S. Heier, M.D.

Chief Scientific OfficeratOcular Therapeutix· In the 2024 proxy

Pay in FY2024Ocular Therapeutix stock +91.5% the same year

Jeffrey S. Heier, M.D. was paid $6.6M in FY2024 (Dec). Ocular Therapeutix stock rose 91.5% that year.

Pay$100 in the stock at the end of FY23 → $191
Pay is from the Summary Compensation Table of each Ocular Therapeutix proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ocular TherapeutixPublic company · 2 yr
    • Chief Scientific Officer2024 – Present · 2 yrStock in role +66%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?